Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
6.29
Dollar change
-0.19
Percentage change
-2.93
%
IndexRUT P/E6.91 EPS (ttm)0.91 Insider Own12.72% Shs Outstand13.02M Perf Week-2.93%
Market Cap81.71M Forward P/E- EPS next Y- Insider Trans-2.49% Shs Float11.34M Perf Month3.45%
Income11.95M PEG2.56 EPS next Q- Inst Own86.39% Short Float9.38% Perf Quarter7.52%
Sales257.55M P/S0.32 EPS this Y- Inst Trans-1.44% Short Ratio3.81 Perf Half Y-62.89%
Book/sh19.25 P/B0.33 EPS next Y- ROA3.04% Short Interest1.06M Perf Year-76.61%
Cash/sh1.18 P/C5.32 EPS next 5Y2.70% ROE4.88% 52W Range4.10 - 32.44 Perf YTD20.27%
Dividend Est.- P/FCF- EPS past 5Y-3.56% ROI3.80% 52W High-80.61% Beta0.42
Dividend TTM- Quick Ratio1.61 Sales past 5Y15.90% Gross Margin69.74% 52W Low53.41% ATR (14)0.48
Dividend Ex-Date- Current Ratio2.16 EPS Y/Y TTM-49.41% Oper. Margin16.49% RSI (14)56.51 Volatility9.82% 9.11%
Employees135 Debt/Eq0.29 Sales Y/Y TTM-5.38% Profit Margin4.64% Recom3.00 Target Price17.00
Option/ShortYes / Yes LT Debt/Eq0.25 EPS Q/Q153.33% Payout0.00% Rel Volume0.46 Prev Close6.48
Sales Surprise9.36% EPS Surprise12.38% Sales Q/Q-12.80% EarningsNov 16 BMO Avg Volume279.23K Price6.29
SMA208.54% SMA5017.82% SMA200-51.91% Trades Volume128,500 Change-2.93%
Date Action Analyst Rating Change Price Target Change
Aug-10-23Downgrade Piper Sandler Neutral → Underweight $26 → $17
Aug-09-23Downgrade Piper Sandler Neutral → Underweight $26 → $17
Apr-07-21Resumed RBC Capital Mkts Outperform $52
Nov-01-18Downgrade Cantor Fitzgerald Overweight → Neutral
Oct-31-18Downgrade Piper Jaffray Overweight → Neutral
Mar-21-18Reiterated Mizuho Underperform $37 → $40
Nov-09-17Reiterated RBC Capital Mkts Outperform $81 → $75
Sep-06-17Reiterated Mizuho Underperform $40 → $37
Jul-27-17Reiterated RBC Capital Mkts Outperform $94 → $81
Jul-27-17Reiterated Mizuho Underperform $57 → $40
Feb-05-24 09:55AM
Feb-01-24 04:05PM
Jan-26-24 12:33PM
Jan-24-24 09:45AM
Jan-18-24 06:50AM
10:12AM Loading…
Jan-12-24 10:12AM
Jan-10-24 10:00AM
Jan-08-24 05:43PM
Jan-05-24 02:03PM
Jan-01-24 09:50AM
Dec-29-23 02:21PM
Dec-25-23 11:07AM
Dec-22-23 01:59PM
Dec-18-23 02:31PM
Dec-14-23 02:18PM
02:30PM Loading…
Dec-11-23 02:30PM
Dec-06-23 04:05PM
Dec-05-23 03:59PM
Dec-04-23 03:19PM
08:00AM
Dec-01-23 03:06PM
12:59PM
Nov-30-23 04:30PM
Nov-29-23 02:50PM
07:35AM
07:30AM
Nov-27-23 09:35AM
Nov-10-23 09:35AM
Nov-09-23 07:30AM
Nov-08-23 08:30AM
10:00AM Loading…
Nov-02-23 10:00AM
Oct-24-23 08:40AM
Oct-23-23 06:50AM
Oct-13-23 08:36AM
Oct-04-23 06:50AM
Sep-19-23 04:05PM
Sep-11-23 06:50AM
Aug-30-23 06:50AM
Aug-29-23 06:50AM
Aug-22-23 04:05PM
Aug-17-23 06:50AM
Aug-11-23 09:40AM
Aug-09-23 07:13AM
Aug-08-23 08:15AM
07:03AM
06:50AM
Aug-01-23 06:50AM
Jul-31-23 06:50AM
Jul-24-23 06:50AM
Jul-18-23 08:56AM
Jul-11-23 06:14AM
Jun-15-23 06:50AM
Jun-14-23 06:50AM
Jun-02-23 06:46PM
May-11-23 06:50AM
May-09-23 08:05AM
07:03AM
06:50AM
May-05-23 06:21AM
May-01-23 06:50AM
Apr-27-23 04:30PM
Apr-26-23 08:00PM
Apr-05-23 06:50AM
Mar-25-23 08:01AM
Mar-14-23 11:26AM
Mar-13-23 11:11PM
08:05AM
06:50AM
Mar-09-23 04:10PM
Mar-03-23 06:50AM
Jan-10-23 02:00PM
Jan-03-23 07:09AM
Dec-29-22 09:40AM
Dec-21-22 04:30PM
Dec-19-22 06:50AM
Dec-13-22 09:40AM
Dec-12-22 06:50AM
Dec-06-22 05:50AM
Dec-01-22 06:50AM
Nov-16-22 06:50AM
Nov-14-22 06:50AM
Nov-09-22 06:50AM
05:22AM
Nov-07-22 08:05AM
06:50AM
Nov-03-22 09:40AM
Nov-02-22 10:01AM
Nov-01-22 10:24AM
Oct-31-22 06:50AM
Oct-19-22 04:39PM
Oct-12-22 06:50AM
Oct-03-22 06:50AM
Sep-27-22 10:59AM
06:50AM
Sep-26-22 08:06AM
Sep-09-22 06:36AM
Aug-30-22 04:05PM
Aug-18-22 12:53PM
Aug-15-22 06:20AM
Aug-09-22 12:00PM
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tarriff ScottCEONov 02Sale13.8710,694148,326545,447Nov 03 04:39 PM
Tarriff ScottCEONov 01Sale13.8210,925150,984556,141Nov 03 04:39 PM
Graves MichaelDirectorOct 27Option Exercise4.949,36046,23810,360Oct 31 05:41 PM
Tarriff ScottCEOOct 03Sale14.4610,734155,174567,066Oct 04 05:07 PM
Tarriff ScottCEOOct 02Sale15.239,511144,853577,800Oct 04 05:07 PM
Tarriff ScottCEOMay 16Sale19.9815,000299,700587,311May 18 05:22 PM
Tarriff ScottCEOMay 15Sale21.0715,000315,9921,594,934May 15 08:34 PM
Tarriff ScottCEOMay 12Sale20.2715,000304,0141,609,934May 15 08:34 PM
Tarriff ScottCEOMay 11Sale20.7115,000310,6501,624,934May 15 08:34 PM